DeepLife

📍 Paris, France🗓 Founded 2019👥 28 employees💰 Last funded Aug 2024
DeepLife is an early stage startup founded in 2019 by Jonathan Baptista and Jean-Baptiste Morlot, backed by international investors, developing the first SaaS platform for Digital Twin of cells. While we are able to design and build incredibly complex mechanical engines, engineering biological systems, such as cells, remains a challenge. However, recent technological improvements, notably in biochemistry, recently enabled the construction of databases with millions of quantitative cell activity measures, covering multiple diseases. The DeepLife team develops a SaaS platform combining state-of-the-art deep learning algorithms on multi-omics sequencing data, public and private cell atlases, and proprietary deep learning-based cell engineering tools. Our goal is to supplement in vitro testing with in silico simulations and rapidly discover molecular triggers to efficiently engineer cell behavior. We are working closely with biotech and pharmaceutical companies to accelerate their target identification processes. We are also collaborating actively with the academic community by publishing papers and providing open access to our platform’s features and data.
6
Total investors
3
Early stage
3
Mid stage
0
Late stage
2019
Founded
Investor geography2 countries
France
5
Germany
1
Investor activity2020–2024 · investors recorded per year
20202202112022220241
Recent (last 2y)Earlier
Frequently asked questions
Who invested in DeepLife?
DeepLife has 6 investors on record on gritt.io, including 3 early-stage backers, 3 mid-stage.
When did DeepLife last raise funding?
The most recent investment in DeepLife recorded on gritt.io was in August 2024.
When was DeepLife founded?
DeepLife was founded in 2019.
What industry is DeepLife in?
DeepLife operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is DeepLife based?
DeepLife is headquartered in Paris, France.